(VIANEWS) – Shares of TherapeuticsMD (NASDAQ Composite: TXMD) jumped 5.5% to $0.78 at 13:21 EST on Tuesday, following the last session’s upward trend. NASDAQ Composite is rising 0.71% to $15,128.91, after four successive sessions in a row of gains. This seems, so far, a somewhat bullish trend exchanging session today.

TherapeuticsMD’s last close was $0.74, 73.09% below its 52-week high of $2.75.


Today’s last reported volume for TherapeuticsMD is 3443593 which is 31.62% below its average volume of 5036246.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the present quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.


TherapeuticsMD’s last week, last month’s, and last quarter’s current volatility was a positive 1.52%, a negative 0.14%, and a positive 3.68%, respectively.

TherapeuticsMD’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.28% (last week), 3.87% (last month), and 3.68% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.78 at 13:21 EST, way below its 52-week high of $2.75 and way higher than its 52-week low of $0.67.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s value is higher than its 50-day moving average of $0.75 and way under its 200-day moving average of $1.04.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here